| # | Drug | Count |
|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 2 |
| 1 | ATROPINE INJECTION, 2 MG | 1 |
| 2 | ATROPINE SULFATE INJECTION USP, 0.5 MG/0.7 ML | 1 |
| 3 | ATROPINE SULFATE INJECTION USP, 1 MG/0.7 ML | 1 |
| 4 | ECULIZUMAB | 1 |
| 5 | MIDAZOLAM INJECTION, 10 MG | 1 |
| 6 | N/A | 1 |
| 7 | TADALAFIL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 2 | 0.0009 |
| 1 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 2 | ECULIZUMAB | 1 | 0.0000 |
| 3 | TADALAFIL | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anticholinergic [EPC] | 1 |
| 1 | Benzodiazepine [EPC] | 1 |
| 2 | Cholinergic Muscarinic Antagonist [EPC] | 1 |
| 3 | Complement Inhibitor [EPC] | 1 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anticholinergic [EPC] | 1 | 0.0001 |
| 1 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 2 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Benzodiazepine [EPC] | 1 | 0.0000 |